| Home \ Media \ Media Coverage |
|
Media Coverage
Search for:
in:
Pharma Marketletter
Less price flexibility, more innovation
Date: 16 October 2006
Dr Meir Pugatch, Head of the Stockholm Network IP and Competition Programme, talks to Pharma Marketletter about generic drugmakers and biosimilars
 FDI ForeignDirectInvestment
Russia pulls up the drawbridge
Date: 05 October 2006
It is Gazprom’s aggressive pursuit of overseas assets that is raising serious concerns in Europe – most prominently, its 51% stake in the North European Gas Pipeline (NEGP), which will transport gas under the Baltic sea into Germany. The undersea route, which bypasses the Baltic states, Belarus and Poland, has added around $3bn to the total cost of the project, leading to speculation that economic considerations are secondary to political motives. Upon completion in 2010, the NEGP will vastly increase Gazprom’s access into the lucrative western European market – it currently provides 30% of Europe’s gas – while allowing it to bypass and isolate current eastern European transit countries, such as Ukraine and Poland.
Managing Intellectual Property Magazine
Flavour of the Month in Brussels
Date: 30 September 2006
At a recent seminar in Brussels, co-organizd by the Stockholm network, the leading pan-European think tank and market-oriented network, and MIP European SMEs were again on the agenda. More specifically, the topic for discussion was: Do IP rights represent a barrier to innovation or an engine for growth for SMEs?
The issue of IP rights and their usefulness to SMEs is certainly a hot topic in Brussels, and the attendees at the seminar expressed a renage of different views. More interesting, however, was the fact that the SMEs themselves could not agree on one specific model for IP exploitation. Prospect Magazine
Prospect Think Tank of the Year Awards
Date: 26 September 2006
David Walker said "the past year has been a good one for tankery. We received a number of strong recommendations and the publications field was outstanding." Among tanks commended by the judges were Reform, Centre for Cities, the Stockholm Network, the Work Foundation, the New Local Government Network, the Constitution Unit, the Social Market Foundation and Civitas.
National Review Online
Stethoscope Socialism
Date: 13 September 2006
In America, patients and doctors often make medical decisions and thus demand the best-available diagnostic tools, procedures, and drugs. Affordability obviously plays its part, but the fact that most Americans either pay for themselves or carry various levels of insurance guarantees a market whose profits reward medical innovators.
Under socialized medicine, public officials administer a single budget and usually ration care among a population whose sole choice is to take whatever therapies the state monopoly provides. “In a service that is free at the point of delivery, demand will always tend to outstrip supply,” explains David Smith. In Impatient for Change: European Attitudes to Healthcare Reform, published by the free-market Stockholm Network, he adds: “[R]ationing by waiting times or by the range of treatments on offer has been a regular feat |
Download the full article: Less price flexibility, more innovation